Implicit bias among physicians and its prediction of thrombolysis decisions for black and white patients

Related Experiment Videos

Alexander R Green1, Dana R Carney, Daniel J Pallin

  • 1The Disparities Solutions Center, Massachusetts General Hospital, Harvard Medical School, 50 Staniford Street, Suite 901, Boston, MA 02114, USA. argreen@partners.org

Abstract

Insights

Physicians exhibit unconscious racial bias, favoring white patients. This implicit bias influences clinical decisions, impacting treatment recommendations for conditions like acute coronary syndromes, potentially widening health disparities.

Area of Science:

  • Medical Ethics
  • Health Disparities Research
  • Psychology of Healthcare

Background:

  • Racial and ethnic disparities in healthcare are often linked to physicians' unconscious biases.
  • Previous research has not quantitatively assessed physicians' unconscious racial bias to determine its impact on clinical decisions.

Purpose of the Study:

  • To investigate the presence of implicit race bias in physicians.
  • To determine if the magnitude of implicit bias predicts thrombolysis recommendations for Black and White patients presenting with acute coronary syndromes.

Main Methods:

  • An internet-based study involving clinical vignettes and Implicit Association Tests (IATs) was administered to internal medicine and emergency medicine residents.
  • Participants (n=287) were randomized to vignettes featuring either a Black or White patient with acute coronary syndrome.
  • IAT scores measured implicit race preference and perceived cooperativeness, alongside explicit bias assessments and thrombolysis decision-making.

Main Results:

  • Physicians reported no explicit racial bias or differences in perceived patient cooperativeness.
  • IATs revealed significant implicit preference for White Americans and negative stereotypes regarding Black Americans' cooperativeness.
  • Increased pro-White implicit bias correlated with a higher likelihood of recommending thrombolysis for White patients and not for Black patients.

Conclusions:

  • This study provides the first empirical evidence of unconscious (implicit) race bias in physicians and demonstrates its predictive validity for clinical decisions.
  • The findings suggest that physicians' implicit biases, distinct from explicit biases, may contribute to racial disparities in the utilization of critical medical procedures like thrombolysis for myocardial infarction.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...